How Do Vaccines Work? Training Your Immune System to Fight

Your Immune System: A Quick Overview

To understand vaccines, you first need to understand how your immune system fights disease naturally.

Your body has two layers of immune defense. The innate immune system is your first responder — non-specific defenses that attack any foreign invader. This includes physical barriers (skin, mucous membranes), white blood cells called neutrophils that engulf invaders, and inflammatory responses that increase blood flow to infected areas. The innate system responds within minutes but treats all threats the same way.

The adaptive immune system is your specialist force. When the innate system can't contain a threat, the adaptive system activates. It produces two key cell types: B cells (which produce antibodies — Y-shaped proteins that lock onto specific pathogens and neutralize them) and T cells (which directly kill infected cells and coordinate the overall immune response).

The adaptive response takes 7-14 days to fully activate during a first encounter — which is why you feel sick for about a week when you catch a new virus. But here's the crucial part: after the infection is cleared, a subset of B and T cells become memory cells that persist for years or decades. If the same pathogen appears again, these memory cells mount a massive response within hours, often destroying the invader before symptoms even develop.

This is why you generally only get chickenpox once. Your first exposure builds immune memory; subsequent exposures are crushed before they gain a foothold. Vaccines exploit this same mechanism — they build immune memory without requiring the dangerous first infection.

How Different Vaccine Types Work

There are several approaches to creating vaccines, each with advantages and tradeoffs.

Live-attenuated vaccines use a weakened (attenuated) form of the actual pathogen that can replicate in the body but is too weak to cause disease. Examples include the MMR vaccine (measles, mumps, rubella) and the oral polio vaccine. These produce the strongest and longest-lasting immunity — often lifelong from a single dose — because they closely mimic a natural infection. However, they can't be given to immunocompromised patients and require refrigeration.

Inactivated vaccines use pathogens that have been killed with heat or chemicals. The flu shot and the hepatitis A vaccine are examples. They're safer than live vaccines but generally produce weaker immunity, requiring multiple doses (boosters) to maintain protection.

Subunit vaccines use only a piece of the pathogen — typically a protein from its surface. The hepatitis B vaccine and the HPV vaccine use this approach. They're very safe (no possibility of causing the disease) but may need adjuvants (immune-boosting additives) to produce a strong enough response.

mRNA vaccines (like the Pfizer-BioNTech and Moderna COVID-19 vaccines) represent a revolutionary new approach. Instead of introducing the pathogen or its parts, they deliver genetic instructions (messenger RNA) that tell your cells to temporarily produce a harmless piece of the pathogen — specifically, the spike protein of SARS-CoV-2. Your immune system recognizes this protein as foreign and mounts a full response, building memory without ever encountering the actual virus. The mRNA degrades within days and never enters the cell nucleus or alters your DNA.

Herd Immunity: Protecting Those Who Can't Be Vaccinated

Herd immunity occurs when enough people in a population are immune to a disease that it can no longer spread effectively, indirectly protecting those who cannot be vaccinated — newborns, elderly individuals with weakened immune systems, cancer patients undergoing chemotherapy, and people with severe allergies to vaccine components.

The threshold for herd immunity depends on how contagious the disease is, measured by the basic reproduction number (R₀) — the average number of people one infected person will infect in a fully susceptible population. Measles, one of the most contagious diseases known, has an R₀ of 12-18, meaning each infected person spreads it to 12-18 others. To achieve herd immunity against measles, approximately 95% of the population must be immune. For COVID-19 (original strain, R₀ ≈ 2.5), the threshold was roughly 60-70%.

When vaccination rates drop below the herd immunity threshold, outbreaks return. The United States experienced measles outbreaks in 2019 (1,282 cases, the most since 1992) in communities where vaccination rates had declined, often due to misinformation about vaccine safety.

The concept of herd immunity also explains why individual vaccination is a collective responsibility. Every unvaccinated person who can safely receive a vaccine represents a potential link in the chain of transmission that could reach someone who is genuinely vulnerable.

The Greatest Success Story in Medical History

Vaccines have prevented more death and suffering than any other medical intervention in human history.

Smallpox killed approximately 300 million people in the 20th century alone — more than all wars combined. Edward Jenner's smallpox vaccine (1796) led to a global eradication campaign that succeeded in 1980. The last natural case occurred in Somalia in 1977. No human has contracted smallpox since. This remains the only human disease ever deliberately eradicated.

Polio paralyzed roughly 35,000 Americans annually in the early 1950s. The Salk vaccine (1955) and Sabin oral vaccine (1961) have reduced global polio cases by 99.9% — from 350,000 annual cases in 1988 to fewer than 200 in recent years. Eradication is within reach, with the virus remaining endemic in only Afghanistan and Pakistan.

The WHO estimates that vaccines prevent 3.5-5 million deaths every year from diseases including diphtheria, tetanus, whooping cough, influenza, and measles. The measles vaccine alone has prevented an estimated 56 million deaths between 2000 and 2021.

mRNA technology, accelerated by the COVID-19 pandemic, is now being developed for cancer vaccines (personalized vaccines targeting individual patients' tumor mutations), HIV, malaria, influenza, and autoimmune diseases. The speed of COVID-19 vaccine development — from viral genome sequencing to authorized vaccine in 11 months — was unprecedented and demonstrated that mRNA platforms can respond to novel threats far faster than traditional vaccine approaches.

Vaccine hesitancy, driven largely by misinformation, remains a significant public health challenge. The fraudulent 1998 Wakefield study claiming a link between the MMR vaccine and autism was thoroughly debunked by dozens of studies involving millions of children, and Wakefield lost his medical license. No credible evidence links any vaccine to autism.

Sources: WHO vaccine fact sheets, CDC immunization data, Jenner Institute (Oxford), Moderna and Pfizer-BioNTech clinical trial publications, Global Polio Eradication Initiative.